Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001535610-18-000002
Form Type:
13G Filing
Publication Date:
2018-01-03 17:20:06
Filed By:
Sabby Capital
Company:
Arno Therapeutics Inc (OTCMKTS:ARNI)
Filing Date:
2018-01-03
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sabby Healthcare Master Fund, Ltd 0 1,081,108 0 1,081,108 1,081,108 2.19 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 042564203 1. NAME OF REPORTING PERSONS Sabby Volatility Warrant Master Fund, Ltd. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 241,319 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 241,319 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 241,319 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.49 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 042564203 1. NAME OF REPORTING PERSONS Sabby Management, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,322,427 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,322,427 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,322,427 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.68 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO CUSIP No. 042564203 1. NAME OF REPORTING PERSONS Hal Mintz 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,322,427 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,322,427 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,322,427 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.68 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN CUSIP No. 042564203 Item 1. (a). Name of Issuer Arno Therapeutics, Inc. (b). Address of issuer s principal executive offices 200 Route 31 North, Suite 104, Flemington, NJ 08822 Item 2. (a). Name of person filing Sabby Healthcare Master Fund, Ltd. Sabby Volatility Warrant Master Fund, Ltd. Sabby Management, LLC Hal Mintz (b). Address or principal business office or, if none, residence Sabby Healthcare Master Fund, Ltd. c o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. c o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458 Hal Mintz c o Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458 (c). Citizenship Sabby Healthcare Master Fund, Ltd. - Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. - Cayman Islands Sabby Management, LLC - Delaware, USA Hal Mintz - USA (d). Title of class of securities Common stock (the Common Stock) (e). CUSIP No. 042564203 Item 3. If This Statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E) (f) An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F) (g) A parent holding company or control person in accordance with Section 240.13d- 1(b)(1)(ii)(G) (h) A savings association as defined in Section 3(b) of the Federal Deposit nsurance Act (12 U.S.C.1813) (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J) (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned Sabby Healthcare Master Fund, Ltd. - 1,081,108 Sabby Volatility Warrant Master Fund, Ltd. - 241,319 Sabby Management, LLC - 1,322,427 Hal Mintz - 1,322,427 (b) Percent of class Sabby Healthcare Master Fund, Ltd. - 2.19%
Sabby Volatility Warrant Master Fund, Ltd 0 241,319 0 241,319 241,319
Sabby Management 0 1,322,427 0 1,322,427 1,322,427
Hal Mintz 0 1,322,427 0 1,322,427 1,322,427
Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.5)* Arno Therapeutics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 042564203 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ? CUSIP No. 042564203

1. NAME OF REPORTING PERSONSSabby Healthcare Master Fund, Ltd.2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY4. CITIZENSHIP OR PLACE OF ORGANIZATIONCayman IslandsNUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER06. SHARED VOTING POWER 1,081,1087. SOLE DISPOSITIVE POWER08. SHARED DISPOSITIVE POWER 1,081,1089. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,081,10810. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_]11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)2.1912. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 0425642031. NAME OF REPORTING PERSONSSabby Volatility Warrant Master Fund, Ltd.2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY4. CITIZENSHIP OR PLACE OF ORGANIZATIONCayman IslandsNUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER6. SHARED VOTING POWER 241,3197. SOLE DISPOSITIVE POWER08. SHARED DISPOSITIVE POWER 241,3199. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 241,31910. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_]11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)0.4912. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 0425642031. NAME OF REPORTING PERSONSSabby Management, LLC2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY4. CITIZENSHIP OR PLACE OF ORGANIZATIONDelaware, USANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER06. SHARED VOTING POWER 1,322,4277. SOLE DISPOSITIVE POWER08. SHARED DISPOSITIVE POWER 1,322,4279. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,322,42710. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_]11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO CUSIP No. 0425642031. NAME OF REPORTING PERSONSHal Mintz2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY4. CITIZENSHIP OR PLACE OF ORGANIZATIONUSANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER06. SHARED VOTING POWER 1,322,4277. SOLE DISPOSITIVE POWER08. SHARED DISPOSITIVE POWER 1,322,4279. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,322,42710. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_]11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)2.6812. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN CUSIP No. 042564203 Item 1. (a). Name of Issuer:Arno Therapeutics, Inc. (b). Address of issuer's principal executive offices:200 Route 31 North, Suite 104, Flemington, NJ 08822 Item 2. (a). Name of person filing:Sabby Healthcare Master Fund, Ltd. Sabby Volatility Warrant Master Fund, Ltd. Sabby Management, LLC Hal MintzSabby Healthcare Master Fund, Ltd. c/o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. c/o Ogier Fiduciary Services (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458 Hal Mintz c/o Sabby Management, LLC 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458(c). Citizenship:Sabby Healthcare Master Fund, Ltd. - Cayman Islands Sabby Volatility Warrant Master Fund, Ltd. - Cayman Islands Sabby Management, LLC - Delaware, USA Hal Mintz - USA(d). Title of class of securities:Common stock (the Common Stock) (e). CUSIP No.:042564203 Item 3. If This Statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a (a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [_] An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Section 240.13d- 1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit nsurance Act (12 U.S.C.1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [_] A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) [_] Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution:( (c) Number of shares as to which the person has: Sabby Healthcare Master Fund, Ltd. ( (i) Sole power to vote or to direct the vote 0 ,( (ii) Shared power to vote or to direct the vote 1,081,108 ,( (iii) Sole power to dispose or to direct the disposition of 0 ,( (iv) Shared power to dispose or to direct the disposition of 1,081,108 .Sabby Volatility Warrant Master Fund, Ltd. ( (i) Sole power to vote or to direct the vote 0 ,( (ii) Shared power to vote or to direct the vote 241,319 ,( (iii) Sole power to dispose or to direct the disposition of 0 ,( (iv) Shared power to dispose or to direct the disposition of 241,319 .Sabby Management, LLC (i) Sole power to vote or to direct the vote 0 ,( (ii) Shared power to vote or to direct the vote 1,322,427 ,( (iii) Sole power to dispose or to direct the disposition of 0 ,( (iv) Shared power to dispose or to direct the disposition of 1,322,427 .Hal Mintz ( (i) Sole power to vote or to direct the vote 0 ,( (ii) Shared power to vote or to direct the vote 1,322,427 ,( (iv) Shared power to dispose or to direct the disposition of 1,322,427 .As calculated in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended, (i) Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd. beneficially own 1,081,108 and 241,319 shares of the Issuer's common stock (Common Stock), respectively, representing approximately 2.19% and 0.49% of the Common Stock, respectively, and each of Sabby Management, LLC and Hal Mintz beneficially owns 1,322,427 shares of the Common Stock,representing approximately 2.68% of the Common Stock. Sabby Management, LLC and Hal Mintz do not directly own any shares of Common Stock, but each indirectly owns 1,322,427 shares of Common Stock. Sabby Management, LLC, a Delaware limited liability company, indirectly owns 1,322,427 shares of Common Stock because it serves as the investment manager of Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd. Mr. Mintz indirectly owns 1,322,427 shares of Common Stock in his capacity as manager of Sabby Management, LLC. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.Not applicable Item 8. Identification and Classification of Members of the Group.Not applicable Item 9. Notice of Dissolution of Group.Not applicable ? Item 10. Certification.By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. ? SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 3, 2018 (Date)Sabby Healthcare Master Fund, Ltd. By: /s/ Harry Thompson Name: Harry Thompson Title: Authorized Person of TDF Management Ltd., a Director Sabby Volatility Warrant Master Fund, Ltd. By: /s/ Harry Thompson Name: Harry Thompson Title: Authorized Person of TDF Management Ltd., a Director Sabby Management, LLC* By: /s/ Robert Grundstein Name: Robert Grundstein Title: Chief Operating Officer/s/ Hal Mintz Hal Mintz